Zyprexa Class Action Lawsuit Settlement
ZYPREXA ALERT> Zyprexa Diabetes or Diabetic Ketoacidosis Class Action Lawsuits
A number of Zyprexa Class action lawsuits have been filed over the last few years. If you or a loved one have been diagnosed with diabetes, pancreatitis or diabetic ketoacidosis after taking Zyprexa, you should consider receiving a free legal evaluation of a potential Zyprexa claim or lawsuit. There is no charge for the Zyprexa lawsuit consultation. You may be entitled to a Zyprexa lawsuit or part of a Zypreza Class Action lawsuit and zyprexa settlment already on file. Call a Zyprexa Lawyer at 1-800-883-9858 to discuss if a class action lawsuit is best for you.
Zyprexa, Pancreatitis & Diabetes
According to medical experts, Zyprexa may be linked to causing diabetes, pancreatitis, hyperglycemia (elevated blood sugar levels), and a potentially fatal complication of diabetes called diabetic ketoacidosis in some patients. In September 2003, Eli Lilly sent a Dear Doctor Letter regarding Zyprexa and the FDA issued a request to the manufacturer of the very popular antipsychotic medication Zyprexa, used to treat schizophrenia and bipolar disorder, to add a warning to the drug's label of a possible link between Zyprexa and diabetes. See FDA Zyprexa Warning
Zyprexa Class Action Lawsuits
If you or a loved one have been diagnosed with diabetes, pancreatitis or diabetic ketoacidosis after taking Zyprexa, you should consider receiving a free legal evaluation of a potential Zyprexa claim or class action lawsuit. There is no charge for the Zyprexa class action lawsuit consultation. We work on a contingency fee basis. This means that if you do not receive a financial benefit from your case, there is no charge for our services. Call and speak with a Zyprexa lawyer about a Zyprexa diabetes class action lawsuit or Zyprexa diabetic ketoacidosis injury lawsuit and the current Zyprexa class action lawsuit and Zyprexa lawsuit settlement.
Call a Zyprexa Class Action Lawsuit Attorney at 1-800-883-9858
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment